Related Experiment Videos
Identification of needs in biomarker research
1Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston 77555-1110, USA. jonathan.ward@utmb.edu
Environmental Health Perspectives
|October 1, 1996
Summary
Biological markers (biomarkers) show promise for predicting disease risk early. Further development and societal agreement are needed for effective public health implementation of these valuable tools.
Area of Science:
- Environmental Health
- Toxicology
- Preventive Medicine
Background:
- Growing interest in using biological markers (biomarkers) to assess future disease risk.
- Biomarkers represent observable endpoints in the progression from toxic exposure to disease.
- Early detection of risk through biomarkers is crucial for disease prevention strategies.
Purpose of the Study:
- To highlight key needs for advancing biomarker development and implementation.
- To address challenges in translating technical biomarker advancements into practical public health tools.
Main Methods:
- Discussion of four critical areas for biomarker development: new biomarker discovery, understanding biomarker-disease relationships, characterizing biomarker performance (sensitivity, specificity, variability), and validating predictive capabilities.
- Identification of societal impediments to the widespread use of biomarkers in public health.
Main Results:
- Significant technical progress in biomarker development has outpaced their implementation in human populations.
- Four major needs identified: developing new biomarkers, clarifying biomarker-disease links, improving biomarker validation and characterization, and overcoming societal barriers.
Conclusions:
- Further research is essential to develop novel biomarkers and understand their relationship with disease pathology.
- Robust validation and characterization of biomarker sensitivity, specificity, and variability are critical for accurate risk prediction.
- Establishing societal consensus on the ethical and appropriate use of biomarker data is necessary for their effective integration into public health initiatives.